Rachel Warren
Rachel Warren is a contributing Motley Fool stock market analyst covering pharmaceuticals, biotechnology, medical devices, information technology, and consumer goods. Prior to The Motley Fool, Rachel was a paralegal and legal administrator. She holds a bachelor’s degree in paralegal studies from Liberty University School of Law.
Recent Articles by Rachel Warren

Jan 27, 2025
by Rachel Warren
How to Invest in Vanguard Short-Term Bond ETF (BSV)

Jan 25, 2025
by Rachel Warren
SPDR S&P Biotech ETF (XBI): How to Buy

Jan 22, 2025
by Rachel Warren
Investing in Textile Stocks

Jan 8, 2025
by Rachel Warren
How to Buy Archer Aviation (ACHR)

Jan 8, 2025
by Rachel Warren
How to Invest in Paycor Stock (PYCR)

Jan 8, 2025
by Rachel Warren
How to Invest in Joby Aviation (JOBY)

Dec 28, 2024
by Rachel Warren
How to Invest in Oklo

Nov 27, 2024
by Rachel Warren
How to Invest in Golden Goose Pre-IPO

Nov 26, 2024
by Rachel Warren
How to Invest in Intuitive Machines (LUNR)

Nov 26, 2024
by Rachel Warren
How to Invest in Hims & Hers Health (HIMS)

Nov 26, 2024
by Rachel Warren
How to Invest in Warner Bros Discovery (WBD)

Nov 26, 2024
by Rachel Warren
How to Invest in Vanguard Real Estate ETF (VNQ)

Nov 26, 2024
by Rachel Warren
How to Invest in Live Nation Entertainment Stock (LYV)

Nov 23, 2024
by Rachel Warren
2 Incredible Growth Stocks to Buy With $1,000 Right Now

Nov 23, 2024
by Rachel Warren
2 Unstoppable Dividend Stocks to Buy Now With $500
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.